The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Myasthenia Gravis

In brief

Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also gives rise to subsequent challenges in caregiving, affecting both the patients' families and society.

Key facts

Study ID
NCT06881173
Run by
Cheng, yu-ting
People needed
112
Starts
2022-06-14
Expected to finish
2025-06-13
Last updated by the study team
2025-03-20

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.